Baxter International Inc. presented data at the American Society of Nephrology’s 2016 Kidney Week that indicates its Sharesource telehealth platform is helping physicians recognize adverse issues early, enabling faster treatment (Abstract #PO023), and the Amia automated peritoneal dialysis system, is helping a clinic reduce training times by more than one day, per patient (Abstract #PO1047).
“Data on the use of Baxter’s AMIA APD system and the SHARESOURCE telehealth platform tell us the technology is enhancing dialysis clinic efficiencies,” said Dheerendra Kommala, MD, vice president, medical affairs, Baxter. “For the first time, physicians have more reliable visibility to their patient’s home therapy, which helps them identify potential clinical and therapy adherence issues sooner so that informed decisions can be addressed more quickly.”
- The Sharesource platform data was discussed in a case study from the Geneva University Hospital in Geneva, Switzerland. Health care providers at the hospital offer Sharesource with Baxter’s Homechoice Claria APD system. For one patient, the hospital initially observed no remote patient management alerts and normal PD cycle volume profiles. Then, Sharesource conveyed red flag alerts of prolonged drain times for the patient, which allowed the hospital clinicians to make an early diagnosis and surgically reposition a displaced catheter. Catheter malposition and dysfunction is one of the leading causes for dropout from PD and transfer to hemodialysis (HD).
- A simulation study of 12 APD patient profiles suggests remote management of APD patients through telehealth can save approximately $22,000 in total health care resources (Abstract #PO483). The study identified saved health care resources associated with treatment non-adherence, fluid overload, missing data and other issues, enabling earlier medical intervention to help avoid complications and treatment drop-out.
- Data presented on Amia also indicated how a clinic was able to provide more efficient training for patients, helping those on Amia to go home at least one day sooner than on the legacy APD system. These conclusions were reached in a retrospective review of patients on Amia and the Homechoice system by the Icahn School of Medicine, Mount Sinai, Renal Division in New York.